[3H]phenytoin binding in rat cortical membranes is associated with a micromolar affinity site through which diazepam can exert an enhancing effect.
Abstract-Specific
[3H]phenytoin binding in rat cortical membranes is associated with a micromolar affinity site through which diazepam can exert an enhancing effect.
In contrast to diazepam, (+)bicuculline, isoguvacine and pentobarbital inhibited phenytoin binding, while GABA and (-)baclofen had no effect. Decreased phenytoin binding and a loss of the diazepam effect were observed in phospholipase A2-treated membranes.
Binding in the absence and presence of diazepam demon strated differential postnatal development. Furthermore, the degree to which binding was enhanced by diazepam varied from one brain region to another.
The regional variations of phenytoin binding, both in the presence and absence of diazepam, did not correlate positively with the regional distribution of either the central benzodiazepine receptors or the peripheral type binding sites in the brain.
Since 1981, there have been several reports on the existence of phenytoin binding sites in rat brain membranes (1) (2) (3) (4) . The binding of [3H] phenytoin to these sites was reported to be reversible and saturable, and there are ap parently two distinct populations of sites, a high affinty site and a low affinity site with Kd values of 6-15 nM and 0.7-100 aM, respec tively. Furthermore, the binding is enhanced by diazepam and (+)bicuculline (2, 4) , but inhibited by the barbiturates (1) . It is, how ever, controversial as diazepam was also re ported to displace phenytoin binding at these sites (3) . This is an important point that needs clarification since phenytoin and diazepam potentiate each other in their protective effects against electroconvulsion in mice (5). We have recently confirmed that diazepam, at micromolar concentrations, enhances specific phenytoin binding. Interestingly, only Ro 5-4864, but not clonazepam and Ro 15 1788, enhances phenytoin binding in much the same manner as diazepam (6, 7) . It was suggested that the site at which diazepam enhances phenytoin binding is a novel micro molar affinity site. This report further docu ments various properties of the specific [3H] phenytoin binding in rat brain.
Materials and Methods
Sprague-Dawley rats (male, 200-250 g), obtained from the University Laboratory Animals Center, were sacrificed by cervical dislocation. The brain was removed quickly on ice, and the cerebral cortex dissected from the rest of the brain. In regional studies, the whole brain was separated into seven dis tinct regions. In developmental studies, pre gnant rats close to term were obtained from the Laboratory Animals Center and kept in the laboratory until they gave birth. Litters were sacrificed at the postnatal ages of 1-3, 11-12, and 21-22 days.
Tissues were homogenized by a cell disrupter (Kinematica Polytron, speed set ting 6) in 50 vol. of 50 mM Tris buffer, pH 7. All homogenates were then centrifuged at 30, 000xg, 4°C, and the resulting pellets were resuspended in the same buffer followed by incubation at 37°C for 20 min. For experi ments where the effect of phospholipase A2 (PLA2i was studied, the enzyme was added before this incubation period to a concentra tion of 0.1 U/ml together with CaCl2 (5 mM, final Diazepam (10 I) dissolved in dimethylsulfoxide (DMSO) was added to give final concentrations of 10 nM to 0.1 mM. Other compounds were dissolved in buffer except (+)bicuculline which was dissolved in DMSO. After incubating at 2-4°C for 1 hr, the samples were filtered under vacuum through Whatman glass fiber filters (GF/B). Filters were washed with 2 x 3 ml ice-cold physiolo gical saline and then put into disposable scin tillation vials with 8 ml scintillant (10 g PPO, 0.2 g POPOP, 16 g naphthalene in 2 I of a 5:5:3 mixture of toluene-dioxane-methanol).
5,5-[Phenyl-4-3H (N)] -diphenylhydantoin was purchased from New England Nuclear, specific activity approx. 50 Ci/mmol; unlabel led phenytoin and PLA2 (from Naja naja venom) were from Sigma. Diazepam was a gift from Roche. All other chemicals were of analytical grade. (Table 1) . GABA related compounds gave very interesting results. (+) Bicuculline and isoguvacine inhibited binding by 41 and 25%, respectively, while (-)baclofen had no effect. Pentobarbital inhibited binding by as much as 38%, in sharp contrast to the effect of diazepam which enhanced phenytoin binding by 2.3-fold (Table 1) . Diazepam, however, did not enhance the nonspecific binding. The enhancement occurred in a con centration -dependent manner, with fifty percent enhancement (EC50) occurring at approximately 2 ,uM diazepam (Fig. 1) .
Kinetics of diazepam enhanced phenytoin binding: In the presence of diazepam, specific [3H]phenytoin binding was measured at varying concentrations of phenytoin ranging from 5 nM to 30 ,uM. The binding was found to be saturable (Fig. 2, inset) . Analysis by the Scatchard plot (Fig. 2) revealed a low af finity binding site as well as a high affinity site. Apparent Kd values were 31 ±10 nM for the high affinity sites and 7.2±1.0 ,uM for the low affinity sites.
Brain regional distribution: In the absence of diazepam, specific [3H]phenytoin binding in the seven regions studied showed that the hippocampus, striatum, cerebellum, thalamus/ hypothalamus and cortex had a significantly higher binding than the brain stem. The midbrain had an intermediate binding which was not statistically different from the binding in either the hippocampus or the brain stem (Fig. 3) . In the presence of diazepam, how ever, the cerebellum and striatum showed higher binding, the hippocampus had inter mediate binding, while the cortex, brain stem, midbrain and thalamus/hypothalamus had lower binding. The degree of enhancement in binding by diazepam also varied from region to region with enhancement factors of 2.3 for cortex, 1.6 for thalamus/hypothalamus, 2.8 for cerebellum, 2.2 for midbrain, 2.1 for hip pocampus, 2.5 for striatum and 3.2 for brain stem. In the presence of diazepam, F(6,42)=6.31, P<0.01. *Significant dif ference from the thalamus/hypothalamus, **signifi cant difference from the cerebellum. In contrast to diazepam, all other com pounds tested either inhibited or had no effect on the high affinity phenytoin binding. Of the six neurotransmitters, which were re ported by Burnham et al. (1) not to have any effect, NA and ACh were observed to inhibit the binding by a moderate extent of 20-26%, just reaching statistical significance. It is suspected that the inconsistency may be a result of experimental variations due to a low specific to nonspecific ratio as discussed be fore. On the other hand, the enhancing effect of diazepam and the inhibitory effect of pentobarbital are consistent with previous findings (1, 2) . The GABAA antagonist (+) bicuculline, however, inhibited rather than enhanced (4) phenytoin binding. The GABAA agonist isoguvacine also inhibited phenytoin binding, although to a lesser degree. (-) Baclofen, a GABAB agonist, did not inhibit phenytoin binding, nor did GABA itself. These results may suggest that the phenytoin sites are not associated with the GABA systems. If so, the ability of bicuculline and isoguvacine to interfere with phenytoin binding would seem unrelated to their actions on the GABAA receptors. Moreover, the opposing effects of diazepam and pentobarbital may also support the non-involvement of the GABAA receptor complex where both drugs enhance the effect of GABA on the chloride ion channel.
We have provided in this study two other supportive evidence for the idea of a novel micromolar affinity diazepam site linked with the phenytoin binding site (7, 6) . Firstly, the postnatal increase in phenytoin binding in the absence of diazepam reflects the development of the phenytoin binding sites. It is apparent that about 70% of this site was already present at 1-3 days of age and near adult level was attained in two weeks, indicating early maturation.
On the other hand, phenytoin binding in the presence of diazepam at 1-3 days of age was only about 30% of the adult level, which was attained in more than three weeks time. 
